Lakewood, Colorado, February 4, 2019 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record revenues and adjusted operating income for the third quarter ended December 31, 2018. In comparison to the same quarter in the prior year, third quarter revenues increased 13 percent to $26,682,000, operating income increased 113…
DetailsLakewood, Colorado, July 9, 2018 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 17, 2018, to shareholders of record at the close of business…
DetailsMay 16, 2018, Lakewood, Colorado – A recent study from Taiwan determined that kidney failure patients that begin seeing a nephrologist early on before starting dialysis may help prevent major cardiovascular events. Of more than 60,000 patients reviewed, all of them received pre-dialysis care in some way. Forty percent had early, frequent visits, 21% with…
DetailsMay 10, 2018, Lakewood, Colorado – Mesa Labs’ BGI PQ200 FRM Sampler uses BGI pioneering technology to meet the U.S. Environmental Protection Agency’s (EPA) requirements for ambient particulate sampling. Mesa Lab’s has made product enhancements to the PQ200 which provides new features for better handling of data, improved calibration functionality, field update, and easier access…
DetailsMay 8, 2018, Lakewood, Colorado – As many may know, Mesa Labs is in the process of moving all of the Biological Indicator (BI) divisions to our new facility in Bozeman, Montana. As such, many updates and notifications are posted regularly on our BI website. This information includes: Relocation News Consolidated Product Comparison Charts Product…
Details
